Pharmacogenomics Now: Minimize Risk & Maximize Economic Benefits

Montreal, Quebec (November 05-06, 2008)

Génome Québec and Cambridge Healthtech Institute's Second International Congress will be focused on possibilities in pharmacogenomics. The conference will consist of three main sessions: Setting the Stage for Pharmacogenomics, Phase III & IV and Post/Marketing Surveillance and Risk Mitigation Strategies.

Gene discovery for complex diseases has met unprecedented success over the past year. Pharmacogenetics has also experienced progress, though not at the same level. We need to understand how the emerging knowledge and the methods that have proven successful for complex disease genetics can be employed to facilitate drug discovery and development. Here we consider the role of genetics in specific points of intervention for differentiation of medicines.

More: http://www.pharmacogenomicsnow.com/